Aclaris Therapeutics, Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6 7 8 9 10 11
Rok finansowy 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 2 10 4 6 7 30 31 19
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% inf% 499.6% -58.1% 53.3% 4.3% 340.1% 5.0% -40.1%
Marża brutto 0.0% 0.0% 0.0% 0.0% 28.3% 32.1% 4.1% 20.8% 30.3% 59.8% 42.1% 85.1%
EBIT (mln) -5 -9 -21 -49 -72 -135 -111 -51 -65 -85 -97 -142
EBIT Δ r/r 0.0% 62.3% 142.2% 135.0% 49.1% 87.0% -18.0% -54.2% 28.4% 30.2% 14.3% 45.8%
EBIT (%) 0.0% 0.0% 0.0% 0.0% -4303.2% -1341.9% -2627.3% -785.4% -967.1% -286.2% -311.6% -758.2%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 5 0 0
EBITDA (mln) -5 -9 -21 -49 -72 -135 -74 -51 -41 -80 -134 -52
EBITDA(%) 0.0% 0.0% 0.0% 0.0% -4303.2% -1341.9% -1751.8% -785.4% -607.1% -267.7% -430.1% -276.3%
Podatek (mln) 0 0 -0 -0 -2 3 29 -0 23 2 -0 0
Zysk Netto (mln) -5 -9 -21 -48 -69 -133 -143 -51 -114 -89 -88 -132
Zysk netto Δ r/r 0.0% 62.7% 141.4% 133.8% 42.5% 93.7% 7.6% -64.2% 123.4% -22.4% -0.2% 49.3%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% -4071.5% -1315.4% -3379.5% -789.2% -1690.3% -298.0% -283.1% -705.5%
EPS -0.49 -0.8 -3.37 -2.25 -2.44 -4.03 -3.46 -1.2 -2.01 -1.36 -1.27 -1.71
EPS (rozwodnione) -0.49 -0.8 -3.37 -2.25 -2.44 -4.03 -3.46 -1.2 -2.01 -1.36 -1.27 -1.71
Ilośc akcji (mln) 11 11 6 21 28 33 41 43 57 65 70 77
Ważona ilośc akcji (mln) 11 11 6 21 28 33 41 43 57 65 70 77
Waluta USD USD USD USD USD USD USD USD USD USD USD USD